UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 104

Sortiert nach

Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography-Tandem Mass Spectrometry: Current State and Future Vision

Clinical chemistry (Baltimore, Md.), 2020-02, Vol.66 (2), p.282-301

2020

Volltextzugriff (PDF)

Biomarkers in Pharmaceutical Research

Clinical chemistry (Baltimore, Md.), 2015-11, Vol.61 (11), p.1343-1353

2015

Volltextzugriff (PDF)

Plasma MicroRNAs as Sensitive and Specific Biomarkers of Tissue Injury

Clinical chemistry (Baltimore, Md.), 2009-11, Vol.55 (11), p.1977-1983

2009

Volltextzugriff (PDF)

Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS Assays

Scientific reports, 2019-01, Vol.9 (1), p.114-114, Article 114

2019

Volltextzugriff (PDF)

Quantification of tau in cerebrospinal fluid by immunoaffinity enrichment and tandem mass spectrometry

Clinical chemistry (Baltimore, Md.), 2014-04, Vol.60 (4), p.683-689

2014

Volltextzugriff (PDF)

Cystatin C: An Improved Estimator of Glomerular Filtration Rate?

Clinical chemistry (Baltimore, Md.), 2002-05, Vol.48 (5), p.699-707

2002

Volltextzugriff (PDF)

Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance Test

Clinical chemistry (Baltimore, Md.), 2016-01, Vol.62 (1), p.227-235

2016

Volltextzugriff (PDF)

Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection

Clinical infectious diseases, 2020-06, Vol.71 (1), p.81-86

2020

Volltextzugriff (PDF)

Achieving efficient digestion faster with Flash Digest: potential alternative to multi‐step detergent assisted in‐solution digestion in quantitative proteomics experiments

Rapid communications in mass spectrometry, 2017-01, Vol.31 (2), p.193-199

2017

Volltextzugriff (PDF)

Experimental Medicine Study to Measure Immune Checkpoint Receptors PD‐1 and GITR Turnover Rates In Vivo in Humans

Clinical pharmacology and therapeutics, 2021-06, Vol.109 (6), p.1575-1582

2021

Volltextzugriff (PDF)

Testing For SARS‐CoV‐2: The Day the World Turned its Attention to the Clinical Laboratory

Clinical and translational science, 2020-09, Vol.13 (5), p.871-876

2020

Volltextzugriff (PDF)

Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort

Journal of Alzheimer's disease, 2015-01, Vol.44 (2), p.525

2015

Volltextzugriff (PDF)

A candidate plasma protein classifier to identify Alzheimer's disease

Journal of Alzheimer's disease, 2015-01, Vol.43 (2), p.549

2015

Volltextzugriff (PDF)

Quantitative determination of human interleukin 22 (IL-22) in serum using Singulex-Erenna® Technology

Journal of immunological methods, 2013-04, Vol.390 (1-2), p.30-34

2013

Volltextzugriff (PDF)

Identification of Novel Brain Biomarkers

Clinical chemistry (Baltimore, Md.), 2006-09, Vol.52 (9), p.1713-1721

2006

Volltextzugriff (PDF)

84 Quantifying pharmacodynamic biomarker changes in immuno-oncology by mass spectrometry

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A92-A93

2020

Volltextzugriff (PDF)

Nonspecific binding of Aβ42 to polypropylene tubes and the effect of Tween-20

Clinica chimica acta, 2010-11, Vol.411 (21), p.1833-1833

2010

Volltextzugriff (PDF)

The clinical utility of mass spectrometry based protein assays

Clinica chimica acta, 2016-08, Vol.459, p.155-161

2016

Volltextzugriff (PDF)

The Brain Injury Biomarker VLP-1 Is Increased in the Cerebrospinal Fluid of Alzheimer Disease Patients

Clinical chemistry (Baltimore, Md.), 2008-10, Vol.54 (10), p.1617-1623

2008

Volltextzugriff (PDF)

A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer Disease

The journal of applied laboratory medicine, 2020-01, Vol.5 (1), p.15-28

2020

Volltextzugriff (PDF)

Quantitation of human peptides and proteins via MS: review of analytically validated assays

Bioanalysis, 2014-01, Vol.6 (13), p.1843-1857

2014

Volltextzugriff (PDF)

An evaluation of an aptamer for use as an affinity reagent with MS: PCSK9 as an example protein

Bioanalysis, 2016-08, Vol.8 (15), p.1557-1564

2016

Volltextzugriff (PDF)

Development and validation of an IA-LC/MS method to quantitate active and total B-type natriuretic peptide in human plasma

Bioanalysis, 2016-11, Vol.8 (22), p.2341-2349

2016

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(72)

Publikationsform

Sprache

Englisch
(104)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography-Tandem Mass Spectrometry: Current State and Future Vision

Biomarkers in Pharmaceutical Research

Plasma MicroRNAs as Sensitive and Specific Biomarkers of Tissue Injury

Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS Assays

Quantification of tau in cerebrospinal fluid by immunoaffinity enrichment and tandem mass spectrometry

Cystatin C: An Improved Estimator of Glomerular Filtration Rate?

Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance Test

Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection

Achieving efficient digestion faster with Flash Digest: potential alternative to multi‐step detergent assisted in‐solution digestion in quantitative proteomics experiments

Experimental Medicine Study to Measure Immune Checkpoint Receptors PD‐1 and GITR Turnover Rates In Vivo in Humans

Testing For SARS‐CoV‐2: The Day the World Turned its Attention to the Clinical Laboratory

Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort

A candidate plasma protein classifier to identify Alzheimer's disease

Quantitative determination of human interleukin 22 (IL-22) in serum using Singulex-Erenna® Technology

Identification of Novel Brain Biomarkers

84 Quantifying pharmacodynamic biomarker changes in immuno-oncology by mass spectrometry

Nonspecific binding of Aβ42 to polypropylene tubes and the effect of Tween-20

The clinical utility of mass spectrometry based protein assays

The Brain Injury Biomarker VLP-1 Is Increased in the Cerebrospinal Fluid of Alzheimer Disease Patients

A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer Disease

Quantitation of human peptides and proteins via MS: review of analytically validated assays

An evaluation of an aptamer for use as an affinity reagent with MS: PCSK9 as an example protein

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2 - hybrid LBA/LCMS and input from regulatory agencies)

Development and validation of an IA-LC/MS method to quantitate active and total B-type natriuretic peptide in human plasma

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid [beta]42

Suchergebnisse filtern